CIBC Asset Management
MIRM icon

CIBC Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

CIBC Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
1,866
-503
-21% -$50.5K ﹤0.01% 1264
2026
Q1 		$219K Buy
+2,369
New +$223K ﹤0.01% 1176

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Asset Management's MIRM Position: Q2 2026 in Review

CIBC Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 21% in Q2 2026, selling an estimated $50.5K and leaving 1,866 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

CIBC Asset Management first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. The position peaked at $219K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • CIBC Asset Management held 1,866 shares of Mirum Pharmaceuticals worth $218K as of Q2 2026.
  • CIBC Asset Management sold 503 Mirum Pharmaceuticals shares in Q2 2026, an estimated $50.5K.
  • Mirum Pharmaceuticals made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #1264 holding.
  • CIBC Asset Management first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • CIBC Asset Management's Mirum Pharmaceuticals position peaked at $219K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.